Deutsche Bank Starts Sutro Biopharma (STRO) at Buy, 'favorable risk/reward'
Tweet Send to a Friend
(Updated - November 8, 2023 4:17 PM EST)
Deutsche Bank analyst James Shin initiates coverage on Sutro Biopharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Deutsche Bank analyst James Shin initiates coverage on Sutro Biopharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
